• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外用5-氟尿嘧啶作为角化棘皮瘤的主要治疗方法。

Topical 5-fluorouracil as primary therapy for keratoacanthoma.

作者信息

Gray R J, Meland N B

机构信息

Department of Surgery, Mayo Clinic Scottsdale, AZ 85259, USA.

出版信息

Ann Plast Surg. 2000 Jan;44(1):82-5. doi: 10.1097/00000637-200044010-00015.

DOI:10.1097/00000637-200044010-00015
PMID:10651372
Abstract

Keratoacanthoma is a common, benign cutaneous neoplasm that displays rapid growth on sun-exposed skin. Keratoacanthomas usually involute spontaneously after several months but rarely progress to squamous cell carcinoma. Because this is a benign, self-limited lesion of exposed skin, effective treatment should emphasize patient comfort and cosmetic results in addition to effectiveness. The authors present 2 patients with keratoacanthomas treated with topical 5-fluorouracil. Both patients had complete resolution of their lesions within 8 weeks. The cosmetic result was superb in both patients. Patient satisfaction with this therapy was excellent. Treatment can be instituted based on a clinical diagnosis; no diagnostic biopsy is necessary. Most keratoacanthomas respond to topical 5-fluorouracil therapy within 3 weeks, whereas squamous cell carcinomas respond poorly. Any lesion that shows a poor response after 3 weeks of therapy or that does not resolve within 8 weeks should undergo prompt excisional biopsy for definitive diagnosis and treatment. Topical 5-fluorouracil is an effective, convenient, relatively inexpensive treatment for keratoacanthoma that produces excellent cosmetic results. It should be added to the therapeutic armamentarium of all physicians who treat keratoacanthoma.

摘要

角化棘皮瘤是一种常见的良性皮肤肿瘤,在暴露于阳光下的皮肤上生长迅速。角化棘皮瘤通常在数月后自行消退,但很少进展为鳞状细胞癌。由于这是一种暴露皮肤的良性、自限性病变,除了有效性外,有效的治疗还应注重患者舒适度和美容效果。作者介绍了2例接受局部5-氟尿嘧啶治疗的角化棘皮瘤患者。两名患者的病变均在8周内完全消退。两名患者的美容效果都非常好。患者对这种治疗的满意度很高。可根据临床诊断进行治疗;无需进行诊断性活检。大多数角化棘皮瘤在3周内对局部5-氟尿嘧啶治疗有反应,而鳞状细胞癌反应较差。任何在治疗3周后反应不佳或在8周内未消退的病变都应立即进行切除活检以明确诊断和治疗。局部5-氟尿嘧啶是一种有效、方便且相对便宜的治疗角化棘皮瘤的方法,能产生极佳的美容效果。它应被纳入所有治疗角化棘皮瘤的医生的治疗手段中。

相似文献

1
Topical 5-fluorouracil as primary therapy for keratoacanthoma.外用5-氟尿嘧啶作为角化棘皮瘤的主要治疗方法。
Ann Plast Surg. 2000 Jan;44(1):82-5. doi: 10.1097/00000637-200044010-00015.
2
Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg.5-氟尿嘧啶与铒:钇铝石榴石激光联合治疗一例复发性小腿巨大角化棘皮瘤
Dermatol Surg. 2004 Dec;30(12 Pt 2):1556-60. doi: 10.1111/j.1524-4725.2004.30559.x.
3
Treatment of multiple keratoacanthomas with intralesional fluorouracil.
J Am Acad Dermatol. 1982 Jul;7(1):126-9. doi: 10.1016/s0190-9622(82)80019-4.
4
Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.成功非手术治疗切除难治性发疹性角化棘皮瘤。
Dermatol Online J. 2020 Mar 15;26(3):13030/qt0g36s6sp.
5
Unusual multiple keratoacanthoma in a child successfully treated with 5-fluorouracil.一名儿童罕见的多发性角化棘皮瘤经5-氟尿嘧啶成功治疗。
J Dermatol. 1997 Aug;24(8):546-8. doi: 10.1111/j.1346-8138.1997.tb02838.x.
6
Treatment of keratoacanthoma with topical application of fluorouracil.
Arch Dermatol. 1982 May;118(5):309-11.
7
[The local treatment of the keratoacanthoma with 5-fluorouracil].5-氟尿嘧啶对角化棘皮瘤的局部治疗
Hautarzt. 1975 Nov;26(11):585-8.
8
Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil.离心性边缘性角化棘皮瘤:对局部应用5-氟尿嘧啶的反应
J Am Acad Dermatol. 2006 May;54(5 Suppl):S218-9. doi: 10.1016/j.jaad.2005.07.023.
9
Treatment of keratoacanthomas with intralesional fluorouracil.
Arch Dermatol. 1978 Dec;114(12):1779-83.
10
Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.爆发性鳞状异型(也称为爆发性角化棘皮瘤):疾病实体的定义和通过病灶内 5-氟尿嘧啶成功治疗。
J Am Acad Dermatol. 2019 Jul;81(1):111-122. doi: 10.1016/j.jaad.2018.10.014. Epub 2019 May 15.

引用本文的文献

1
Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.局部注射氨甲喋呤与 5-氟尿嘧啶治疗角化棘皮瘤的疗效比较。
Arch Dermatol Res. 2024 Jun 15;316(7):400. doi: 10.1007/s00403-024-03139-1.
2
Design and Study of Nanoceria Modified by 5-Fluorouracil for Gel and Polymer Dermal Film Preparation.用于制备凝胶和聚合物真皮膜的5-氟尿嘧啶修饰纳米氧化铈的设计与研究
Pharmaceuticals (Basel). 2023 Jul 29;16(8):1082. doi: 10.3390/ph16081082.
3
Clinical efficacy of short contact topical 5-Fluorouracil in the treatment of keratoacanthomas: a retrospective analysis.
短程接触外用5-氟尿嘧啶治疗角化棘皮瘤的临床疗效:一项回顾性分析
J Clin Aesthet Dermatol. 2014 Nov;7(11):35-7.
4
Giant keratoacanthoma of the upper extremity treated with mohs micrographic surgery: a case report and review of current treatment modalities.采用莫氏显微外科手术治疗上肢巨大角化棘皮瘤:病例报告及当前治疗方式综述
J Clin Aesthet Dermatol. 2009 Aug;2(8):22-5.